AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35760319 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using 68 preoperative factors to predict postoperative outcomes
Number of subjects: 848
Study 32011497 — intervention group
Group type: EXPERIMENTAL
Intervention: pregabalin + electro-acupuncture (EA) treatment
Number of subjects: 90
Study 32011497 — intervention group
Group type: EXPERIMENTAL
Intervention: pregabalin + Chuna manual therapy (CMT) treatment
Number of subjects: 90
Study 32011497 — intervention group
Group type: COMPARATOR
Intervention: pregabalin administration
Number of subjects: 90
Study 34256725 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led health promotion intervention
Number of subjects: 57
Study 32199584 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid treatment within 3 hours after the onset of acute bleeding
Number of subjects: 28333
Study 32199584 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid treatment
Number of subjects: 28333
Study 34962161 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamified group (with narrative context and rewarding system)
Number of subjects: 283
Study 34962161 — intervention group
Group type: COMPARATOR
Intervention: Nongamified group (with no narrative context or rewarding system)
Number of subjects: 283
Study 32533015 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hygiene products containing stannous ions (TG)
Number of subjects: 16
Study 32533015 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study 34653398 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose)
Number of subjects: 14
Study 35102968 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic curd (Amul's Probiotic Dahi) containing Lactobacillus acidophilus (La5) and Bifidobacterium lactis (Bb12), 100 g two times a day for 21 days
Number of subjects: 62
Study 35102968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study 35728909 — intervention group
Group type: EXPERIMENTAL
Intervention: Telepharmacy care group (customised mobile application and monthly telecommunications)
Number of subjects: 256
Study 35728909 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (community pharmacists service)
Number of subjects: 256
Study 32111199 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions, 2 sessions completed
Number of subjects: 16
Study 32111199 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) sessions
Number of subjects: 16
Study 32713561 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise (twice a week for 8 weeks)
Number of subjects: 64
Study 35093130 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot and ankle mobilisations combined with home stretches for a 6-week period
Number of subjects: 16
Study 35093130 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot and ankle mobilisations combined with home stretches
Number of subjects: 16
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of nicotine use disorder
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of cannabis use disorder
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of alcohol use disorder among male patients
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of alcohol use disorder among Black patients compared to White patients
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of opioid use disorder among Black patients compared to White patients
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of alcohol use disorder among Hispanic patients compared to White patients
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection of cocaine use disorder among Hispanic patients compared to White patients
Number of subjects: 1076
Study 33111239 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider detection rates based on addiction severity
Number of subjects: 1076
Study 33583214 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrofurantoin
Number of subjects: 1
Study 32363929 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib
Number of subjects: 72
Study 35024908 — intervention group
Group type: EXPERIMENTAL
Intervention: Training program on the cognitions and perceptions of workers with a chronic disease
Number of subjects: 59
Study 35024908 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 59
Study 33059105 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1000 mg in 200 mL normal saline)
Number of subjects: 60
Study 33059105 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine (1 mg in 200 mL normal saline)
Number of subjects: 60
Study 36308504 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 min of Qigong practice (verum Qigong group, n = 15)
Number of subjects: 55
Study 36308504 — intervention group
Group type: COMPARATOR
Intervention: 5 min of watching a wildlife video (negative control group, n = 15)
Number of subjects: 55
Study 36308504 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 min of Qigong practice (Qigong-practitioner group, n = 25)
Number of subjects: 55
Study 33807745 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation
Number of subjects: 323
Study 33807745 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate supplementation (placebo)
Number of subjects: 323
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict implementation of the KDIGO bundle
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with the protocol
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Occurrence of any AKI and moderate/severe AKI
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal recovery at day 90
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of renal replacement therapy (RRT)
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality at days 30, 60 and 90
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Major adverse kidney events
Number of subjects: 280
Study 32265240 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety outcomes
Number of subjects: 280
Study 35190080 — intervention group
Group type: EXPERIMENTAL
Intervention: MyTeachingPartner (MTP) coaching; specific dosage not mentioned; duration not specified.
Number of subjects: 0
Study 35190080 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified; no direct comparison mentioned.
Number of subjects: 0
Study 34471542 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized, temperature-reduced dialysate protocol
Number of subjects: 13500
Study 34471542 — intervention group
Group type: COMPARATOR
Intervention: Fixed dialysate temperature of 36.5°C
Number of subjects: 13500
Study 36002956 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation intervention (specific details not provided)
Number of subjects: 28
Study 32713847 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching Recovery Techniques (TRT) programme
Number of subjects: 226
Study 32713847 — intervention group
Group type: COMPARATOR
Intervention: Services as usual (waitlist-control)
Number of subjects: 226
Study 33416918 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation therapy with vitamin-K antagonists
Number of subjects: 6637
Study 33416918 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation therapy with direct oral anticoagulants
Number of subjects: 6637
Study 33416918 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 6637
Study 35546279 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5mg
Number of subjects: 9876
Study 35546279 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9876
Study 34039182 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal Crosslinking (CXL)
Number of subjects: 23
Study 34129396 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 20
Study 34129396 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 20
Study 34842775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose External Beam Radiotherapy (LD-EBRT) 6 × 0.5 Gy
Number of subjects: 25
Study 33328187 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2.5 mg intravitreal bevacizumab and subconjunctival Mitomycin C (group A)
Number of subjects: 56
Study 33328187 — intervention group
Group type: COMPARATOR
Intervention: Subconjunctival Mitomycin C alone (group B)
Number of subjects: 56
Study 34004448 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine supplementation (9 g/day for 2 weeks)
Number of subjects: 118
Study 34004448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study 32699906 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing MOPP gear
Number of subjects: 49
Study 32699906 — intervention group
Group type: COMPARATOR
Intervention: Not wearing MOPP gear
Number of subjects: 49
Study 35104057 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative cognitive testing and lumbar punctures
Number of subjects: 110
Study 33967063 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric muscle strengthening
Number of subjects: 37
Study 33967063 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 34698822 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine consultations
Number of subjects: 1340
Study 34698822 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face consultations
Number of subjects: 1340
Study 33755028 — intervention group
Group type: EXPERIMENTAL
Intervention: W‐SUDs (Woebot for Substance Use Disorders) for 8 weeks
Number of subjects: 101
Study 33558354 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LS) consisting of an individual combined exercise programme of strength and endurance training and nutritional counselling with regular feedback for 6 months.
Number of subjects: 0
Study 33558354 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 36048042 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 16 weeks
Number of subjects: 80
Study 36048042 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT) for 16 weeks
Number of subjects: 80
Study 33493071 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 0
Study 33493071 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 32790844 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid (FA) rescue
Number of subjects: 52
Study 32790844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 34036915 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg/day levothyroxine for 2 months
Number of subjects: 30
Study 34036915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33397249 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg daily for 8 weeks)
Number of subjects: 90
Study 33397249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-curcumin (80 mg daily for 8 weeks)
Number of subjects: 90
Study 33397249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (capsules like curcumin)
Number of subjects: 90
Study 35452569 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week multicomponent care management intervention
Number of subjects: 3
Study 32800508 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan initiated in-hospital
Number of subjects: 0
Study 32800508 — intervention group
Group type: COMPARATOR
Intervention: Sacubitril/valsartan initiated post-discharge
Number of subjects: 0
Study 32800508 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorable NT-proBNP response at 4 weeks
Number of subjects: 0
Study 36220382 — intervention group
Group type: EXPERIMENTAL
Intervention: CADe
Number of subjects: 1245
Study 36220382 — intervention group
Group type: EXPERIMENTAL
Intervention: EAC
Number of subjects: 1245
Study 36220382 — intervention group
Group type: EXPERIMENTAL
Intervention: CADe+EAC
Number of subjects: 1245
Study 36220382 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 1245
Study 34278433 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand oral TDF/emtricitabine for PrEP
Number of subjects: 245
Study 32364838 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone Hydrocoated Stent (Coloplast Imajin® hydro)
Number of subjects: 141
Study 32364838 — intervention group
Group type: COMPARATOR
Intervention: Percuflex™ Plus Stent (Boston Scientific)
Number of subjects: 141
Study 35404972 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab
Number of subjects: 13481
Study 35404972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13481
Study 34669884 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified tissue-selecting therapy stapler combined with complete anal canal preservation surgery
Number of subjects: 200
Study 34669884 — intervention group
Group type: COMPARATOR
Intervention: Milligan‐Morgan surgery
Number of subjects: 200
Study 32312326 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial prophylactic exchange blood transfusion (SPEBT) commencing at ≤ 18 weeks' gestation, performed using automated erythrocytapheresis every 6‐10 weeks until the end of pregnancy, aiming to maintain HbS% or combined HbS/HbC% below 30%.
Number of subjects: 50
Study 32312326 — intervention group
Group type: COMPARATOR
Intervention: Standard care arm will only receive transfusion when clinically indicated.
Number of subjects: 50
Study 36207757 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP adherence
Number of subjects: 35
Study 36207757 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and substance use
Number of subjects: 35
Study 36207757 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health issues
Number of subjects: 35
Study 36207757 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use
Number of subjects: 35
Study 34542039 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Balance Awareness Program (SBAP)
Number of subjects: 97
Study 34542039 — intervention group
Group type: COMPARATOR
Intervention: Health Awareness Program (HAP)
Number of subjects: 97
Study 32813842 — intervention group
Group type: EXPERIMENTAL
Intervention: Reservoir trays
Number of subjects: 46
Study 32813842 — intervention group
Group type: COMPARATOR
Intervention: Non-reservoir trays
Number of subjects: 46
Study 35260381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 11121
Study 35260381 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 11121
Study 34259565 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Carbohydrate Diet (LCD)
Number of subjects: 0
Study 34259565 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 0
Study 32349353 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of potato protein isolate (PP) twice daily (1.6 g/kg/d total protein)
Number of subjects: 24
Study 32349353 — intervention group
Group type: COMPARATOR
Intervention: Control diet (CON) (0.8 g/kg/d total protein)
Number of subjects: 24
Study 35304396 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT (50.4 Gy with capecitabine) followed by consolidation chemotherapy (six cycles of CapeOx)
Number of subjects: 66
Study 35304396 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy (three cycles of CapeOx plus bevacizumab) followed by CRT and consolidation chemotherapy (three cycles of CapeOx)
Number of subjects: 66
Study 33217854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention for reducing depression
Number of subjects: 100
Study 33217854 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 100
Study 33217854 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing intervention for improving life quality
Number of subjects: 100
Study 34511492 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance exercise with blood flow restriction (REBFR)
Number of subjects: 15
Study 34511492 — intervention group
Group type: COMPARATOR
Intervention: High-intensity resistance exercise (RE)
Number of subjects: 15
Study 32988947 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult participants in YKHEMP
Number of subjects: 2037
Study 32988947 — intervention group
Group type: EXPERIMENTAL
Intervention: Children participants in YKHEMP
Number of subjects: 2037
Study 32988947 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult YKDFN participants
Number of subjects: 2037
Study 36017934 — intervention group
Group type: EXPERIMENTAL
Intervention: Local simvastatin (SIM) 2.2 mg in methylcellulose (SIM/MCL)
Number of subjects: 50
Study 36017934 — intervention group
Group type: COMPARATOR
Intervention: Methylcellulose alone (MCL)
Number of subjects: 50
Study 33781315 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based four-phase participatory learning and action (PLA) cycle intervention implemented over 18 months.
Number of subjects: 4680
Study 33781315 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 4680
Study 35872770 — intervention group
Group type: EXPERIMENTAL
Intervention: RBC exchange (3-4 times in 2 days)
Number of subjects: 60
Study 35872770 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment only (control group)
Number of subjects: 60
Study 33468222 — intervention group
Group type: EXPERIMENTAL
Intervention: Huoxiang Zhengqi (HXZQ)
Number of subjects: 218
Study 33468222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 35762321 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (4 grams daily)
Number of subjects: 0
Study 35762321 — intervention group
Group type: COMPARATOR
Intervention: Mineral oil (comparator)
Number of subjects: 0
Study 33288862 — intervention group
Group type: EXPERIMENTAL
Intervention: Midostaurin (50 mg twice daily) with standard-of-care (SOC)
Number of subjects: 60
Study 33288862 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care (SOC)
Number of subjects: 60
Study 35058583 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 200 mg
Number of subjects: 1161
Study 35058583 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 400 mg
Number of subjects: 1161
Study 35058583 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan (both doses)
Number of subjects: 1161
Study 35058583 — intervention group
Group type: COMPARATOR
Intervention: olmesartan 20 mg
Number of subjects: 1161
Study 34363033 — intervention group
Group type: EXPERIMENTAL
Intervention: Total testosterone
Number of subjects: 159702
Study 34363033 — intervention group
Group type: EXPERIMENTAL
Intervention: Free testosterone
Number of subjects: 159702
Study 34363033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex hormone-binding globulin (SHBG)
Number of subjects: 159702
Study 34363033 — intervention group
Group type: COMPARATOR
Intervention: Genetically predicted IGF-1 concentration
Number of subjects: 159702
Study 34574458 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) products (Angelicae Sinensis Radix, Astragali Radix, Salviae Miltiorrhizae Radix et Rhizoma) administered orally for two weeks
Number of subjects: 48
Study 34574458 — intervention group
Group type: COMPARATOR
Intervention: Control group (other CHM products not specified)
Number of subjects: 48
Study 33217532 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled assay
Number of subjects: 127
Study 33217532 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized assay
Number of subjects: 127
Study 33217532 — intervention group
Group type: EXPERIMENTAL
Intervention: Washing of potato strips
Number of subjects: 127
Study 33217532 — intervention group
Group type: COMPARATOR
Intervention: Estimated average dietary exposure
Number of subjects: 127
Study 32224239 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Tricuspid Valve Replacement (MTV)
Number of subjects: 226
Study 32224239 — intervention group
Group type: COMPARATOR
Intervention: Bioprosthetic Tricuspid Valve Replacement (BTV)
Number of subjects: 226
Study 35144297 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioscopically-guided erector spinae plane (ESP) block
Number of subjects: 0
Study 35144297 — intervention group
Group type: COMPARATOR
Intervention: Standard wound infiltration technique with local anaesthetics
Number of subjects: 0
Study 32763086 — intervention group
Group type: EXPERIMENTAL
Intervention: SUGAR Handshake (pharmacist-led patient counselling)
Number of subjects: 0
Study 32763086 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 32132128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual multimedia instructional materials and community health workers assisting in biospecimen collection
Number of subjects: 103
Study 32132128 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based participatory approach
Number of subjects: 103
Study 34763615 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Relational Therapy (BRT)
Number of subjects: 40
Study 34763615 — intervention group
Group type: COMPARATOR
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 40
Study 33706729 — intervention group
Group type: EXPERIMENTAL
Intervention: real a-tDCS (r-tDCS)
Number of subjects: 38
Study 33706729 — intervention group
Group type: EXPERIMENTAL
Intervention: sham tDCS (s-tDCS)
Number of subjects: 38
Study 33706729 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 38
Study 33128132 — intervention group
Group type: EXPERIMENTAL
Intervention: Surefire® anti‐reflux catheter
Number of subjects: 21
Study 33128132 — intervention group
Group type: COMPARATOR
Intervention: Standard microcatheter
Number of subjects: 21
Study 33128132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 21